ABSTRACT
The detection of preclinical dementia has become an important focus of clinical research to enable investigation and early treatment. Alzheimer’s disease (AD) is the most common dementia accounting for at least 50% of cases. Operationalized criteria for dementia emphasize early and prominent memory loss. This assumption is not necessarily valid for those with mild cognitive deficits or dementia related to cerebrovascular disease.
